2020 Legal Life science Value creation 
LaVoie Health Science Blog
JULY 1, 2020
Sharp gains and losses in share prices, together with significant changes in share ownership mean that few companies, particularly those in the life science sector, are immune from the potential disruptions of shareholder activism. In the spring of 2020, in the heat of the COVID-19 crisis, just such a scenario played out.
Tackle.io
SEPTEMBER 21, 2021
Other categories included business applications, education, financial services, retail, manufacturing or industrial, media and entertainment, storage, telecom, government, and healthcare and life sciences. . Respondents represented six annual recurring revenue (ARR) segments, from less than $1 million to more than $1 billion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Tackle.io
OCTOBER 25, 2022
Other categories included business applications, education, financial services, retail, manufacturing or industrial, media and entertainment, storage, telecom, government, and healthcare and life sciences. Respondents represented six annual recurring revenue (ARR) segments, from less than $1 million to more than $1 billion.
Tackle.io
OCTOBER 25, 2022
Other categories included business applications, education, financial services, retail, manufacturing or industrial, media and entertainment, storage, telecom, government, and healthcare and life sciences. . Respondents represented six annual recurring revenue (ARR) segments, from less than $1 million to more than $1 billion.
Expert insights. Personalized for you.
52 
Let's personalize your content